Published in:
Open Access
01-07-2019 | Multiple Sclerosis | Original Research
Multiple Sclerosis Performance Test: Technical Development and Usability
Authors:
Jane K. Rhodes, David Schindler, Stephen M. Rao, Fernando Venegas, Efrosini T. Bruzik, Wendy Gabel, James R. Williams, Glenn A. Phillips, Colleen C. Mullen, Jaime L. Freiburger, Lyla Mourany, Christine Reece, Deborah M. Miller, Francois Bethoux, Robert A. Bermel, Lauren B. Krupp, Ellen M. Mowry, Jay Alberts, Richard A. Rudick
Published in:
Advances in Therapy
|
Issue 7/2019
Login to get access
Abstract
Introduction
In the clinic, the assessment of patients with multiple sclerosis (MS) is typically qualitative and non-standardized.
Objectives
To describe the MS Performance Test (MSPT), an iPad Air® 2 (Apple, Cupertino, CA, USA)-based neurological assessment platform allowing patients to input relevant information without the aid of a medical technician, creating a longitudinal, clinically meaningful, digital medical record. To report results from human factor (HF) and usability studies, and the initial large-scale implementation in a practice setting.
Methods
The HF study examined use-error patterns in small groups of MS patients and healthy controls (n = 14), the usability study assessed the effectiveness of patient interaction with the tool by patients with a range of MS disability (n = 60) in a clinical setting, and the implementation study deployed the MSPT across a diverse population of patients (n = 1000) in a large MS center for routine clinical care.
Results
MSPT assessments were completed by all users in the HF study; minor changes to design were recommended. In the usability study, 73% of patients with MS completed the MSPT, with an average administration time of 32 min; 85% described their experience with the tool as satisfactory. In the initial implementation for routine care, 84% of patients with MS completed the MSPT, with an average administration time of 28 min.
Conclusion
Patients with MS with varying disability levels completed the MSPT with minimal or no supervision, resulting in comprehensive, efficient, standardized, quantitative, clinically meaningful data collection as part of routine medical care, thus allowing for large-scale, real-world evidence generation.
Trial Registration
NCT02664324.